Status:
UNKNOWN
Changes in Haemostasis After Therapeutic Plasmapheresis With Citrate Anticoagulation
Lead Sponsor:
University Medical Centre Ljubljana
Conditions:
Humoral Rejection
Guillain-Barre Syndrome
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Plasma exchange procedures remove procoagulant and anticoagulant factors. Every procedure increases the risk of bleeding and repeated procedures increase the risk of bleeding mostly because lower fibr...
Eligibility Criteria
Inclusion
- Every patient who will need repeated plasmapheresis treatment in UKC Ljubljana
Exclusion
- pregnancy
- coagulation disorders
- Hypertriglyceridemia-induced acute pancreatitis
- hepatic disorders
Key Trial Info
Start Date :
October 3 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 24 2019
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03801135
Start Date
October 3 2018
End Date
September 24 2019
Last Update
January 11 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Centre Ljubljana
Ljubljana, Gorenjska, Slovenia, 1000